US Stock MarketDetailed Quotes

Ginkgo Bioworks (DNA)

Watchlist
  • 7.880
  • +0.040+0.51%
Close Sep 18 16:00 ET
  • 7.880
  • -0.001-0.01%
Post 19:30 ET
530.64MMarket Cap-1.58P/E (TTM)

Ginkgo Bioworks (DNA) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Total Revenue as Reported
-48.49%20.16M
-49.06%19.47M
-23.84%33.40M
-56.39%38.84M
-30.37%39.13M
+0.75%38.23M
+26.16%43.85M
+60.65%89.05M
-30.24%56.21M
-52.98%37.94M
-64.64%34.76M
-16.52%55.43M
-44.29%80.57M
-52.08%80.70M
-33.81%98.29M
-14.45%66.40M
+231.42%144.62M
+281.90%168.41M
+363.20%148.49M
+483.45%77.61M
Total Operating Revenue
-48.49%20.16M
-49.06%19.47M
-23.84%33.40M
-56.39%38.84M
-30.37%39.13M
+0.75%38.23M
+26.16%43.85M
+60.65%89.05M
-30.24%56.21M
-52.98%37.94M
-64.64%34.76M
-16.52%55.43M
-44.29%80.57M
-52.08%80.70M
-33.81%98.29M
-14.45%66.40M
+231.42%144.62M
+281.90%168.41M
+363.20%148.49M
+483.45%77.61M
Cost of Revenue
-68.05%1.72M
-24.25%3.10M
-24.12%7.30M
+6.66%12.80M
-60.79%5.38M
-55.55%4.09M
+45.55%9.62M
+73.38%12.00M
-24.18%13.72M
-58.87%9.20M
-78.12%6.61M
-71.92%6.92M
-71.69%18.10M
-73.81%22.38M
-54.61%30.22M
+10.55%24.66M
+273.53%63.91M
+260.47%85.43M
+380.99%66.58M
+1160.71%22.30M
Gross Profit
-45.38%18.44M
-52.03%16.38M
-23.75%26.10M
-66.21%26.04M
-20.55%33.75M
+18.78%34.14M
+21.61%34.23M
+58.83%77.04M
-31.99%42.49M
-50.72%28.74M
-58.65%28.14M
+16.20%48.51M
-22.59%62.47M
-29.70%58.33M
-16.91%68.07M
-24.53%41.74M
+204.26%80.71M
+306.79%82.97M
+349.69%81.92M
+379.56%55.31M
Operating Expense
-12.86%76.99M
-20.69%87.75M
-28.08%96.14M
-11.59%114.31M
-55.94%88.35M
-46.48%110.65M
-35.19%133.67M
-45.83%129.30M
-18.70%200.51M
-24.57%206.74M
-31.00%206.26M
-65.74%238.69M
-66.15%246.62M
-63.86%274.07M
-83.08%298.93M
+749.82%696.68M
+742.46%728.49M
+878.36%758.34M
+2284.02%1.77B
+78.43%81.98M
Selling and Admin Expenses
-12.02%30.78M
-4.77%37.83M
-19.69%46.01M
-14.03%44.95M
-47.23%34.98M
-43.48%39.72M
-35.78%57.30M
-36.25%52.29M
-35.23%66.29M
-36.92%70.29M
-26.49%89.22M
-81.15%82.03M
-76.66%102.34M
-74.37%111.43M
-84.47%121.38M
+1402.89%435.22M
+1173.02%438.43M
+2325.21%434.77M
+5953.02%781.63M
+193.23%28.96M
-General & Admin Expense
-12.02%30.78M
-4.77%37.83M
-19.69%46.01M
-14.03%44.95M
-47.23%34.98M
-43.48%39.72M
-35.78%57.30M
-36.25%52.29M
-35.23%66.29M
-36.92%70.29M
-26.49%89.22M
-81.15%82.03M
-76.66%102.34M
-74.37%111.43M
-84.47%121.38M
+1402.89%435.22M
+1173.02%438.43M
+2325.21%434.77M
+5953.02%781.63M
+193.23%28.96M
Research & Development
-13.42%46.21M
-29.61%49.92M
-34.37%50.13M
-9.94%69.35M
-60.24%53.37M
-48.03%70.92M
-34.74%76.38M
-50.85%77.01M
-6.97%134.22M
-16.10%136.46M
-34.08%117.04M
-40.08%156.66M
-50.26%144.28M
-49.74%162.64M
-81.98%177.55M
+393.13%261.46M
+457.47%290.06M
+443.05%323.58M
+1509.75%985.03M
+46.99%53.02M
Operating Profit
-7.24%-58.55M
+6.71%-71.37M
+29.57%-70.05M
-68.93%-88.27M
+65.45%-54.60M
+57.02%-76.51M
+44.17%-99.45M
+72.52%-52.26M
+14.19%-158.02M
+17.49%-178.00M
+22.85%-178.12M
+70.96%-190.18M
+71.57%-184.15M
+68.06%-215.75M
+86.30%-230.86M
-2355.53%-654.94M
-980.62%-647.78M
-1082.48%-675.37M
-2914.48%-1.68B
+22.49%-26.67M
Net Non-Operating Interest Income (Expense)
-46.87%3.23M
-40.86%3.60M
-34.97%4.71M
-37.93%5.74M
-41.02%6.08M
-48.07%6.08M
-45.17%7.24M
-38.41%9.25M
-28.13%10.31M
-19.48%11.71M
+16.54%13.21M
+135.42%15.02M
+533.79%14.35M
+8117.51%14.55M
+20709.09%11.34M
+1308.33%6.38M
+573.64%2.26M
+137.26%177.00K
+98.46%-55.00K
-119.37%-528.00K
Non-Operating Interest Income
-46.87%3.23M
-40.86%3.60M
-35.80%4.71M
-37.93%5.74M
-41.02%6.08M
-48.07%6.08M
-44.85%7.34M
-38.41%9.25M
-28.13%10.31M
-19.48%11.71M
--13.30M
--15.02M
+533.79%14.35M
+8117.51%14.55M
----
----
--2.26M
--177.00K
----
----
Total Other Finance Costs
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-1308.33%-6.38M
----
----
----
--528.00K
Other Income (Expense)
+62.18%-1.88M
+34.66%-8.36M
-2.59%-16.06M
+112.89%1.78M
+92.84%-4.96M
-3213.63%-12.80M
+66.69%-15.65M
+89.22%-13.77M
-1910.53%-69.28M
+111.15%411.00K
-248.31%-46.99M
-491.41%-127.75M
+86.27%-3.45M
-104.47%-3.69M
-59.95%31.68M
+71.36%-21.60M
-554.05%-25.10M
+575.11%82.42M
+505.29%79.11M
-1454.63%-75.41M
Gain on Sale of Security
+967.69%1.99M
+34.34%-1.21M
+20.48%-18.02M
+168.42%3.68M
-117.52%-229.00K
-151.25%-1.85M
-555.39%-22.66M
+84.36%-5.38M
+119.79%1.31M
+169.84%3.61M
-122.28%-3.46M
-142.43%-34.43M
+56.46%-6.60M
-106.04%-5.17M
-75.19%15.52M
+53.96%-14.20M
-650.42%-15.16M
+577.27%85.49M
+4923.69%62.55M
-34177.78%-30.85M
Earnings from Equity Interest
---4.67M
----
----
----
--0.00
----
+100.00%0.00
--0.00
+100.00%0.00
+100.00%0.00
-111.19%-1.12M
+100.00%0.00
+99.34%-67.00K
+93.06%-1.45M
+314.52%10.00M
+42.72%-22.71M
-133.92%-10.17M
+27.03%-20.89M
-365.70%-4.66M
-16630.38%-39.65M
Special Income (Charges)
+100.00%0.00
+100.00%0.00
-80.89%1.14M
+82.48%-1.75M
+94.89%-3.57M
-21.07%-6.31M
+114.01%5.96M
+89.65%-9.96M
---69.82M
---5.21M
---42.50M
-701.73%-96.21M
--0.00
----
-100.00%0.00
--15.99M
--0.00
--15.90M
--23.83M
--0.00
-Less:Restructuring and Mergern & Acquisition
-100.00%0.00
-100.00%0.00
-83.02%706.00K
-40.83%1.75M
-79.10%3.57M
--4.47M
--4.16M
--2.95M
--17.07M
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
-Less:Impairment of Capital Assets
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
-100.00%0.00
--47.86M
----
--0.00
--96.21M
--0.00
----
--0.00
--0.00
----
----
----
----
-Less:Write Off
--0.00
-100.00%0.00
----
--0.00
-100.00%0.00
-64.62%1.84M
----
--0.00
--4.90M
--5.21M
----
----
----
----
----
----
----
----
----
----
-Gain on Sale Of Business
----
----
--0.00
+100.00%0.00
----
----
+100.00%0.00
---7.01M
----
----
---42.50M
-100.00%0.00
----
----
--0.00
--15.99M
--0.00
--15.90M
--0.00
--0.00
Other Non-Operating Income (Expenses)
+169.26%809.00K
-54.10%-7.15M
-21.73%821.00K
-110.37%-163.00K
-52.48%-1.17M
-330.17%-4.64M
+1027.96%1.05M
-45.66%1.57M
-123.76%-766.00K
-31.18%2.02M
-98.49%93.00K
+527.96%2.89M
+1301.74%3.22M
+52.58%2.93M
+337.33%6.16M
+86.23%-676.00K
-96.77%230.00K
+242.68%1.92M
-245.52%-2.60M
-183.32%-4.91M
Pretax Profit
-6.95%-57.19M
+8.51%-76.14M
+24.54%-81.39M
-42.23%-80.75M
+75.36%-53.48M
+49.83%-83.22M
+49.10%-107.86M
+81.26%-56.78M
-25.25%-216.99M
+19.04%-165.88M
-12.80%-211.89M
+54.80%-302.91M
+74.17%-173.25M
+65.44%-204.89M
+88.30%-187.85M
-553.10%-670.16M
-1121.63%-670.62M
-691.03%-592.78M
-3361.18%-1.61B
-292.85%-102.61M
Tax
+145.23%128.00K
-190.91%-80.00K
-97.85%-643.00K
+100.27%1.00K
-248.95%-283.00K
+183.87%88.00K
-64.14%-325.00K
-1604.55%-375.00K
+183.58%190.00K
-62.20%31.00K
+98.66%-198.00K
+21.43%-22.00K
+248.89%67.00K
+144.57%82.00K
-2062.52%-14.77M
+86.47%-28.00K
+89.56%-45.00K
-15.72%-184.00K
-8637.50%-683.00K
-3550.00%-207.00K
Net Profit
+22.54%-46.71M
+9.20%-82.59M
+24.91%-80.75M
-43.18%-80.76M
+72.24%-60.30M
+45.18%-90.96M
+49.20%-107.53M
+81.38%-56.40M
-25.31%-217.18M
+19.06%-165.91M
-22.31%-211.69M
+54.80%-302.89M
+74.15%-173.32M
+65.41%-204.97M
+89.22%-173.08M
-554.39%-670.13M
-1131.22%-670.57M
-692.47%-592.59M
-3359.12%-1.60B
-291.97%-102.41M
Profit from Continuing Operations
-7.76%-57.32M
+8.70%-76.06M
+24.91%-80.75M
-43.18%-80.76M
+75.51%-53.19M
+49.79%-83.31M
+49.20%-107.53M
+81.38%-56.40M
-25.31%-217.18M
+19.06%-165.91M
-22.31%-211.69M
+54.80%-302.89M
+74.15%-173.32M
+65.41%-204.97M
+89.22%-173.08M
-554.39%-670.13M
-1131.22%-670.57M
-692.47%-592.59M
-3359.12%-1.60B
-291.97%-102.41M
Net Income from Discontinuous Operations
+249.32%10.61M
+14.63%-6.53M
----
----
---7.11M
---7.65M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Minority Interests
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+155.08%2.39M
+100.00%0.00
-233.65%-1.75M
-72.70%-2.09M
-926.48%-4.34M
-638.03%-524.00K
Net Income to Parent Company
+22.54%-46.71M
+9.20%-82.59M
+24.91%-80.75M
-43.18%-80.76M
+72.24%-60.30M
+45.18%-90.96M
+49.20%-107.53M
+81.38%-56.40M
-25.31%-217.18M
+19.06%-165.91M
-20.65%-211.69M
+54.80%-302.89M
+74.09%-173.32M
+65.29%-204.97M
+89.04%-175.47M
-557.76%-670.13M
-1139.92%-668.83M
-702.65%-590.51M
-3311.17%-1.60B
-291.02%-101.88M
Other Preferred Stock Dividends
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
--29.00K
--184.00K
-24.06%464.00K
----
--0.00
--0.00
--611.00K
----
----
----
----
----
----
Net Income to Common Stockholders
+22.54%-46.71M
+9.20%-82.59M
+24.67%-80.75M
-43.10%-80.76M
+72.26%-60.30M
+45.33%-90.96M
+49.36%-107.20M
+81.37%-56.43M
-25.42%-217.37M
+19.07%-166.38M
-20.65%-211.69M
+54.80%-302.89M
+74.09%-173.32M
+65.19%-205.58M
+89.42%-175.47M
-557.76%-670.13M
-1139.92%-668.83M
-702.65%-590.51M
-3436.08%-1.66B
-291.02%-101.88M
Basic EPS
+31.82%-0.75
+17.26%-1.39
+29.00%-1.42
-34.26%-1.45
+74.00%-1.10
+49.24%-1.68
+53.27%-2.00
+82.61%-1.08
-17.50%-4.23
+24.77%-3.31
-18.89%-4.28
+62.13%-6.21
+78.05%-3.60
+70.27%-4.40
+91.43%-3.60
-412.50%-16.40
-925.00%-16.40
-29775.45%-14.80
-132824.01%-42.00
-18138.81%-3.20
Diluted EPS
+31.82%-0.75
+17.26%-1.39
+29.00%-1.42
-34.26%-1.45
+74.00%-1.10
+49.40%-1.68
+53.27%-2.00
+82.61%-1.08
-17.50%-4.23
+24.55%-3.32
-7.00%-4.28
+62.13%-6.21
+78.05%-3.60
+70.27%-4.40
+90.91%-4.00
-412.50%-16.40
-925.00%-16.40
-29775.45%-14.80
-139153.73%-44.00
-18138.81%-3.20
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More